soul trial oral semaglutide cardiovascular outcomes results 2025 nejm Editorial Fellow Harleen Marwah, MD, summarizes the trial. Visit NEJM.org for the full results. #ACC25 #Cardiology #ClinicalTrials #MedTok #NEJM Michael Albert, MD on X:

Paradoxically, a separate study published in the same journal, around the same time, analyzed body-contouring outcomes in GLP-1 patients, and did not find an increased rate of post-op complications

Shortness of breath does not appear in clinical trial reports as a direct side effect of Ozempic or semaglutide

Each stage is designed for your comfort and safety

You're not following a fixed program that doesn't know how you feel

The standard dosage is 20-40 mg/kg of body weight for 3-6 months once or twice in a day and best if taken at night 2-3 hours after the last meal for better absorption

For some, the sensation is temporary and fades as the body adjusts to the medication